drugset / Trial / NCT00070031

Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy

NCT00070031

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy such as edotecarin use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well edotecarin works in treating women with locally advanced or metastatic breast cancer that has not responded to previous chemotherapy.

Timeline

Start
2003-06
Primary completion
2006-04
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Edotecarin Small molecule Intravenous

Indications